 "ICMR and Japan's NIID to collaborate for antimicrobial resistance research")
Indian Council of Medical Research (ICMR) and Department of Bacteriology, National Institute of Infectious Diseases (NIID) of Japan have signed a letter of intent (LoI) for antimicrobial resistance research. The LoI was signed on the sidelines of the meeting of the Health Ministers from WHO South East Asia Region and Western Pacific Region countries at Tokyo on April 16, 2016.
Terming the collaboration as another significant milestone in the strong ties between the two countries, J P Nadda, Minister for Health & Family Welfare, stated that this will further help in deepening the relations between the two in research and development in scientific areas, particularly public health.
ICMR and NIID will collaborate on the development of integrated surveillance program covering epidemiology data and genomic data of antimicrobial resistance in each country. In addition, the two sides will mutually exchange of information of molecular and epidemiological data of antimicrobial resistance by developing of comparable surveillance program in each country.
Nadda emphasised on the importance of collaborative effort and mobilising the necessary resources for the implementation of antimicrobial resistance national action plans in all countries. He also underscored the need to encourage research and development and discovery of new drugs and ensure equitable and affordable access.
Terming the collaboration as another significant milestone in the strong ties between the two countries, J P Nadda, Minister for Health & Family Welfare, stated that this will further help in deepening the relations between the two in research and development in scientific areas, particularly public health.
ICMR and NIID will collaborate on the development of integrated surveillance program covering epidemiology data and genomic data of antimicrobial resistance in each country. In addition, the two sides will mutually exchange of information of molecular and epidemiological data of antimicrobial resistance by developing of comparable surveillance program in each country.
Nadda emphasised on the importance of collaborative effort and mobilising the necessary resources for the implementation of antimicrobial resistance national action plans in all countries. He also underscored the need to encourage research and development and discovery of new drugs and ensure equitable and affordable access.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%